Received the following news release through Canada StockWatch, today.
Footmaxx appoints Connie Curran to the board
Footmaxx Holdings Inc FTMX
Shares issued 35,766,224 Jan 17 close $0.15
Wed 19 Jan 2000
News Release
Mr. John Fowler reports
At the board of directors meeting held Dec. 16, 1999, Dr. Connie Curran, president and chief executive officer of CurranCare, Illinois, was appointed to the board as the Lawrence & Co. independent director, replacing Gary DeGroote, whose resignation was accepted at this same meeting.
Dr. Curran is the founder and CEO of CurranCare, a national management services company that assists integrated delivery systems improve patient care and financial performance, in part by developing and integrating non-acute care services. Dr. Curran has held several executive positions in health care systems. She is vice-president of the American Hospital Association and was national director of Patient Care Services at APM Inc. Dr. Curran has over 100 publications to her credit, including books on hospital-physician integration, hospital redesign and optimized home care integration.
Dr. Curran is the editor of Nursing Economics. She is an RN and an Ed D.
Dr. Glenn Copeland has resigned as chairman of the board of directors and as a director and officer of the company, effective Jan. 7, 2000. Dr. Copeland, founder of the Footmaxx technology, left his podiatry practice in late 1996 to join Footmaxx full-time in order to assist the company with its progress in sales and marketing, as well as product development. Dr. Copeland states: "I believe the products and concept of Footmaxx to be very sound and also firmly believe that the company will be very successful in the near future. I wish Footmaxx and especially all the investors and shareholders of the company all the best in the mew millennium and hope Footmaxx will become the great success we all expect of it."
The board and management of Footmaxx wish to thank Dr. Copeland for the commitment and leadership he has shown and wish him the best of luck with his group of private clinical practices.
As previously announced in Stockwatch on Sept. 27, Footmaxx retained the professional services of Lenny Simak as president and chief executive officer of Footmaxx. During the previous three-month period Mr. Simak has been working with the Footmaxx senior management team and the board while transitioning into his leadership role. Mr. Simak's skills and background are well suited to the next growth and development phases of the Footmaxx business.
John R. (Ted) Kennedy, vice-chairman will act as chair until a replacement is selected.
In other news, Dr. Alan Lustig, DPM, has returned from sabbatical to rejoin Footmaxx as its senior medical director, effective Jan. 13, 2000.
Dr. Lustig has been an integral part of Footmaxx for the past number of years, counting among his accomplishments the Eight Point Gait Analysis Report Manual, a valuable diagnostic tool for clinicians. His medical knowledge, experience and working relationship with customers are well-known and his return continues to add support to the medical needs of the community.
(c) Copyright 2000 Canjex Publishing Ltd. canada-stockwatch.com
End of News Release.
I haven't been commenting on Footmaxx recently because I find it very hard to get any information from the company.
My e-Mails go unanswered.
Their web site NOW contains no info about financials or directors.
In general, I'm disgusted with their apparent lack of concern about share value.
Still, I'm holding.
Unless they find some clever way to absorb the revenue,
they should become profitable in 2,000.
At least, that's my hope.
Cush |
